Release Date: 26/02/10 16:29 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 169.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%